| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Viracta Therapeutics Inc (NASDAQ: VIRX)
VIRX Technical Analysis
5
| As on 11th Mar 2025 VIRX STOCK Price closed @ 0.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.77 & Strong Sell for SHORT-TERM with Stoploss of 1.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VIRXSTOCK Price
| Open | 0.03 | Change | Price | % |
| High | 0.04 | 1 Day | 0.00 | 0.00 |
| Low | 0.03 | 1 Week | -0.13 | -81.25 |
| Close | 0.03 | 1 Month | -0.18 | -85.71 |
| Volume | 229291 | 1 Year | -1.13 | -97.41 |
| 52 Week High 1.46 | 52 Week Low 0.08 | ||||
NASDAQ USA Most Active Stocks
| SYRS | 0.14 | 55.56% |
| AMRS | 0.14 | 100.00% |
| BHAT | 0.04 | 33.33% |
| NVDA | 108.76 | 1.66% |
| CUTR | 0.11 | -15.38% |
| AWH | 0.18 | -10.00% |
| TSLA | 230.58 | 3.79% |
| LMDX | 0.02 | 0.00% |
| LCID | 2.09 | 0.48% |
| AAL | 11.46 | -8.32% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VIRX Daily Charts |
VIRX Intraday Charts |
Whats New @ Bazaartrend |
VIRX Free Analysis |
|
|
VIRX Important Levels Intraday
| RESISTANCE | 0.05 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| RESISTANCE | 0.04 |
| SUPPORT | 0.02 |
| SUPPORT | 0.02 |
| SUPPORT | 0.02 |
| SUPPORT | 0.01 |
VIRX Forecast March 2025
| 4th UP Forecast | 1.65 |
| 3rd UP Forecast | 1.13 |
| 2nd UP Forecast | 0.81 |
| 1st UP Forecast | 0.49 |
| 1st DOWN Forecast | -0.43 |
| 2nd DOWN Forecast | -0.75 |
| 3rd DOWN Forecast | -1.07 |
| 4th DOWN Forecast | -1.59 |
VIRX Weekly Forecast
| 4th UP Forecast | 0.59 |
| 3rd UP Forecast | 0.41 |
| 2nd UP Forecast | 0.30 |
| 1st UP Forecast | 0.19 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -0.24 |
| 3rd DOWN Forecast | -0.35 |
| 4th DOWN Forecast | -0.53 |
VIRX Forecast2025
| 4th UP Forecast | 2.9 |
| 3rd UP Forecast | 1.98 |
| 2nd UP Forecast | 1.41 |
| 1st UP Forecast | 0.84 |
| 1st DOWN Forecast | -0.78 |
| 2nd DOWN Forecast | -1.35 |
| 3rd DOWN Forecast | -1.92 |
| 4th DOWN Forecast | -2.84 |
Viracta Therapeutics Inc ( NASDAQ USA Symbol : VIRX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VIRX Business Profile
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. It is developing nanatinostat, an oral combination therapy in combination with the antiviral agent valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma. The company was founded in 2007 and is headquartered in Cardiff-by-the-Sea, California. Address: 2533 South Coast Highway 101, Cardiff-by-the-Sea, CA, United States, 92007
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service